Literature DB >> 19765964

The influence of NK alloreactivity on matched unrelated donor and HLA identical sibling haematopoietic stem cell transplantation.

Campbell S Witt1.   

Abstract

Numerous retrospective studies have been reported analysing the role of HLA mismatches that confer donor NK alloreactivity towards the recipient on the outcome of haematopoietic stem cell transplantation. A bewildering variety of findings have been observed with different studies showing either beneficial or deleterious effects on outcome. This review organises the reports into those that use similar definitions of NK alloreactivity, suggests possible reasons for such disparate results and assesses whether any recommendations can be made in relation to donor selection. There is growing evidence that the effect of human NK alloreactivity on outcome is transplant protocol dependent. Protocol variables most likely to affect outcome are those that influence donor T cell numbers. At this time, it is not possible to predict how the outcome of unrelated donor transplantation will be affected by HLA mismatches conferring potential donor NK alloreactivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765964     DOI: 10.1016/j.coi.2009.08.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  6 in total

1.  A perspective on the selection of unrelated donors and cord blood units for transplantation.

Authors:  Stephen R Spellman; Mary Eapen; Brent R Logan; Carlheinz Mueller; Pablo Rubinstein; Michelle I Setterholm; Ann E Woolfrey; Mary M Horowitz; Dennis L Confer; Carolyn K Hurley
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

Review 2.  NK cells: immune cross-talk and therapeutic implications.

Authors:  Anshu Malhotra; Anil Shanker
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

3.  Natural killer cell-based therapies.

Authors:  François Romagné; Eric Vivier
Journal:  F1000 Med Rep       Date:  2011-05-03

4.  Allele-Level KIR Genotyping of More Than a Million Samples: Workflow, Algorithm, and Observations.

Authors:  Ines Wagner; Daniel Schefzyk; Jens Pruschke; Gerhard Schöfl; Bianca Schöne; Nicole Gruber; Kathrin Lang; Jan Hofmann; Christine Gnahm; Bianca Heyn; Wesley M Marin; Ravi Dandekar; Jill A Hollenbach; Johannes Schetelig; Julia Pingel; Paul J Norman; Jürgen Sauter; Alexander H Schmidt; Vinzenz Lange
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

5.  Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals.

Authors:  Cynthia Vierra-Green; David Roe; Lihua Hou; Carolyn Katovich Hurley; Raja Rajalingam; Elaine Reed; Tatiana Lebedeva; Neng Yu; Mary Stewart; Harriet Noreen; Jill A Hollenbach; Lisbeth A Guethlein; Tao Wang; Stephen Spellman; Martin Maiers
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

6.  Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.

Authors:  Rehan Mujeeb Faridi; Taylor J Kemp; Poonam Dharmani-Khan; Victor Lewis; Gaurav Tripathi; Raja Rajalingam; Andrew Daly; Noureddine Berka; Jan Storek; Faisal Masood Khan
Journal:  PLoS One       Date:  2016-06-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.